Bharat Biotech's application for approval of indigenous Covid 19 vaccine, Covaxin has been rejected by the USFDA that cited a lack of sufficient data. The Hyderabad based vaccine maker will now be applying for a full license from the US FDA and a statement put out today says the US FDA has stopped all Emergency Use Approvals for Covid 19 vaccines. The Indian vaccine maker has come under fire recently for not putting out phase 3 trial data in the public domain because of which approval has not been granted by the World Health Organization. Tamanna Inamdar, Senior Editor ET Now explains why Bharat Biotech is facing the heat
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► [ Ссылка ]
Subscribe Now To Our Network Channels :-
Times Now : [ Ссылка ]
The NewsHour Debate : [ Ссылка ]
To Stay Updated Download the Times Now App :-
Android Google Play : [ Ссылка ]
Apple App Store : [ Ссылка ]
Social Media Links :-
Twitter - [ Ссылка ]
Facebook - [ Ссылка ]
G+ - [ Ссылка ]
Website - www.etnownews.com
